SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(O'Byrne P. M.) srt2:(2005-2009)"

Search: WFRF:(O'Byrne P. M.) > (2005-2009)

  • Result 1-2 of 2
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • O'Byrne P, M., et al. (author)
  • Budesonide/Formoterol combination therapy as both maintenance and reliever medication in asthma
  • 2005
  • In: Am J Respir Crit Care Med. ; 171:2, s. 129-36
  • Journal article (peer-reviewed)abstract
    • Asthma control is improved by combining inhaled corticosteroids with long-acting beta(2)-agonists. However, fluctuating asthma control still occurs. We hypothesized that in patients receiving low maintenance dose budesonide/formoterol (bud/form), replacing short-acting beta(2)-agonist (SABA) reliever with as-needed bud/form would provide rapid symptom relief and simultaneous adjustment in antiinflammatory therapy, thereby reducing exacerbations. In this double-blind, randomized, parallel-group study, 2,760 patients with asthma aged 4-80 years (FEV(1) 60-100% predicted) received either terbutaline 0.4 mg as SABA with bud/form 80/4.5 mug twice a day (bud/form + SABA) or bud 320 mug twice a day (bud + SABA) or bud/form 80/4.5 mug twice a day with 80/4.5 mug as-needed (bud/form maintenance + relief). Children used a once-nocte maintenance dose. Bud/form maintenance + relief prolonged time to first severe exacerbation (p < 0.001; primary endpoint), resulting in a 45-47% lower exacerbation risk versus bud/form + SABA (hazard ratio, 0.55; 95% confidence interval, 0.44, 0.67) or bud + SABA (hazard ratio, 0.53; 95% confidence interval 0.43, 0.65). Bud/form maintenance + relief also prolonged the time to the first, second, and third exacerbation requiring medical intervention (p < 0.001), reduced severe exacerbation rate, and improved symptoms, awakenings, and lung function compared with both fixed dosing regimens.
  •  
2.
  • O'Byrne, Justin P., et al. (author)
  • Novel catalysts for carbon nanotube and nanofibre synthesis
  • 2009
  • Conference paper (peer-reviewed)abstract
    • Carbon nanotubes are of huge interest to the scientific community for their physical and electronic properties[1]. We have synthesized carbon nanotubes (CNTs) on novel non-traditonal catalysts. Bamboo-shaped carbon nanotubes (BCNTs) were synthesized on Pd and Cu catalysts doped with either Mo or W. BCNTs were sythesised using the catalytic chemical vapour decomposition (CVD) of methane. Cu is catalytically inactive for the synthesis of CNTs; however this is not the case when Cu is doped with Mo[2] and W. When Cu is doped with these metals bamboo structured CNTs can be produced via a CVD synthesis method. The addition of a dopant alters the electronic structure of catalyst nanoparticle causing the binding strength between the nanoparticle and carbon to approach that of traditional catalysts for CNT growth i.e. Fe; Co; Ni and their alloys which has been shown by computer modeling. We have performed full geometry optimization DFT calculations of Cu/W and Pd/Mo particles of different compositions to determine their ability to stabilize and support the growing end of a CNT. We have computed a (5;0) SWNTs binding energy to a M13 metal cluster (M=Cu; W or Pd; Mo); which in a model system that has been proven to correctly predict the trends in bonding[2; 3]. The resulting binding energies are compared to Fe; Co; Ni and Cu/Mo clusters of these previous reports. All calculations were made using the generalized gradient approximation (GGA) exchange and correlation potential by Perdew-Burke-Ernzenhof [PBE]; utilizing the polarized valence triple-ζ (TZVP) basis set[4] and relativistic effective core potentials (ECPs) for Cu; Pd; W and Mo[5; 6]; as implemented in the Turbomole suite of programs[7-10].
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-2 of 2

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view